|
|
Nuwellis Inc (NASDAQ: NUWE) |
|
Price: $1.0098
$0.19 
23.146%
|
| Day's High:
| $1.4600000381469727
| Week Perf:
| 31.14 %
|
| Day's Low: |
$ 0.85 |
30 Day Perf: |
-15.14 % |
| Volume (M): |
50,036,759 |
52 Wk High: |
$ 6.40 |
| Volume (M$): |
$ 0 |
52 Wk Avg: |
$1.92 |
| Open: |
$0.86 |
52 Wk Low: |
$0.08 |
|
|
| Market Capitalization (Millions $) |
0 |
| Shares
Outstanding (Millions) |
0 |
| Employees |
38 |
| Revenues (TTM) (Millions $) |
9 |
| Net Income (TTM) (Millions $) |
-11 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Nuwellis Inc is a medical device company that specializes in developing and commercializing innovative therapies for patients with chronic heart failure and other fluid overload conditions. The company's flagship product, known as the Aquadex FlexFlow System, is a fluid management system that utilizes ultrafiltration to safely remove excess fluid from patients. This portable system allows patients to manage their fluid balance at home, reducing the need for hospitalization and improving their quality of life. Nuwellis Inc is dedicated to improving patient outcomes and creating more cost-effective solutions for fluid management in the healthcare industry.
Company Address: 12988 Valley View Road Eden Prairie 55344 MN
Company Phone Number: 345-4200 Stock Exchange / Ticker: NASDAQ NUWE
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Management Changes
Published Mon, Feb 24 2025 9:05 PM UTC
Nuwellis, Inc.: Leadership Transition Amidst Financial Growth and Strategic Vision for the FutureIn a transformative period for Nuwellis, Inc. a key player in the medical technology industry, the company recently announced the retirement of Nestor Jaramillo, Jr. as President and CEO. In a corresponding move, John Erb, the current Chair of the Board, has been appointed as the...
|
| Management Announcement
Published Mon, Nov 4 2024 1:30 PM UTC
In a move destined to reshape its financial outlook, Nuwellis Inc. announced a staggering 397% daily increase in the reimbursement rate for its Aquadex SmartFlow Therapy, effective January 1, 2025, from the Centers for Medicare and Medicaid Services (CMS). This monumental improvement comes on the heels of a more modest, but still impressive, 112.88% increase over the trailin...
|
| Shares
Published Tue, Nov 5 2024 2:28 PM UTC
On November 5, 2024, Minneapolis-based Nuwellis, Inc. (Nasdaq: NUWE), a prominent player in the medical technology sector, notably specializing in solutions for fluid overload, announced a significant financial milestone. The company revealed the immediate exercise of certain warrants, yielding approximately $5.1 million in gross proceeds.The warrants exercised consist of ap...
|
| Stock Market Announcement
Published Fri, Aug 23 2024 1:00 PM UTC
In a recent press release, medical technology company Nuwellis, Inc. (Nasdaq: NUWE) has revealed its entry into a definitive securities purchase agreement with select institutional investors. Under this agreement, Nuwellis will undertake a registered direct offering priced at-the-market under Nasdaq rules. The offering will consist of 496,901 shares of the Company ...
|
| Stock Market Announcement
Published Thu, Aug 8 2024 1:00 PM UTC
MINNEAPOLIS, Aug. 08, 2024 - Nuwellis, Inc. (Nasdaq: NUWE), a prominent medical technology company dedicated to revolutionizing the lives of individuals suffering from fluid overload, excitedly announced today that The Nasdaq Hearings Panel (Panel) has granted its request to extend its listing on the Nasdaq Stock Market. This decision comes with certain conditions ...
|
Fundamental Analysis
| Per Share |
Current |
| Earnings (TTM) |
-206.54 $ |
| Revenues (TTM) |
49.73 $
|
| Cash Flow (TTM) |
- |
| Cash |
21.64 $
|
| Book Value |
-
|
| Dividend (TTM) |
0 $ |
| Efficiency
|
Current |
| Revenue per Employee
(TTM) |
237,184 |
| Net
Income per Employee (TTM) |
-298,158 |
| Receivable Turnover Ratio (TTM) |
6.28 |
| Inventory Turnover Ratio (TTM) |
1.43 |
| Asset Turnover Ratio (TTM) |
1.19 |
|
|
| Per Share |
|
| Earnings (TTM) |
-206.54 $
|
| Revenues (TTM) |
49.73 $ |
| Cash Flow (TTM) |
- |
| Cash |
21.64 $
|
| Book Value |
- |
| Dividend (TTM) |
0 $ |
|
|
| |
| Fluid Overload |
|
 222.04 % |
of total Revenue |
|
|
1.89%